Thursday, November 12, 2026

ECB Signals April Rate Hike as Oil Shock Erases Fed Cut Bets Across Major Economies

European Central Bank policymaker Madis Muller warns April rate changes are possible if oil stays elevated, while Fed rate cut probability for 2026 collapsed from two expected cuts in December to just 0.2% chance of any reduction. Central banks from Frankfurt to Beijing now face energy-driven inflation risks as China extends gold buying to 15 months.

LM Salvado
LM Salvado

April 11, 2026

Source Trace Score12 source documents12 with a live linkVerifiability: Strong
ECB Signals April Rate Hike as Oil Shock Erases Fed Cut Bets Across Major Economies
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.

European Central Bank policymaker Madis Muller said the bank "can't rule out changes in interest rates already in April if energy prices remain at a high level for a long time" as oil jumped 3% on Middle East tensions—a warning echoed across major economies facing renewed inflation pressure.1

ECB Governing Council member Olaf Sleijpen reinforced the hawkish turn, stating the bank "will act if needed to keep inflation at target."2 The stance mirrors growing alarm among G10 central banks that sustained energy spikes could force synchronized tightening despite weak growth in Europe and slowing momentum in Asia.

Across the Atlantic, Federal Reserve rate cut expectations have evaporated. CME FedWatch data shows just 0.2% of traders now price rates falling to 3.25-3.5% by December 2026, down from December forecasts of two cuts this year.3 Current pricing assigns 64% probability to unchanged rates through year-end.

The reversal coincides with Fed Chair Jerome Powell's term ending in May 2026, creating leadership uncertainty during an energy crisis. Markets that priced in coordinated easing by major central banks four months ago now face the prospect of divergent policies or synchronized hawkishness.

China's central bank extended gold purchases to 15 consecutive months through January 2026, according to Central Banking data—part of a broader pattern of reserve diversification by emerging market and developed economy central banks hedging against currency and inflation volatility.4

For multinational banks operating across currency zones, the policy shift creates cross-border asset-liability mismatches. European lenders with dollar funding costs face margin compression if ECB rates rise while Fed rates hold. Asian exporters relying on cheap dollar financing confront a harder-for-longer scenario that changes corporate credit dynamics across supply chains.

The ECB's April meeting now carries global weight as the first major central bank decision since oil's surge. A rate hike would signal that inflation control trumps growth support across advanced economies, potentially forcing parallel moves by the Bank of England, Reserve Bank of Australia, and other inflation-targeting central banks watching energy pass-through to core prices.

Source documents

Via News is a conduit. We point to the source documents behind this report — we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score12 source documents12 with a live linkVerifiability: Strong
  1. [1]News articleNasdaq· April 9, 2026
    Dollar Falls in Hopes of De-escalation of Middle East Hostilities
  2. [2]News articleSg· March 30, 2026
    Dollar holds firm as risk of protracted Middle East war saps sentiment
  3. [3]News articleNasdaq· April 9, 2026
    Dollar Slips on Weak US Economic News
  4. [4]News articleYahoo Finance· April 4, 2026
    Goldman Sachs has blunt message on gold price for rest of 2026
  5. [5]News articleNasdaq· March 28, 2026
    Look Beyond Skyrocketing Gas Prices! If a Stock Market Crash Takes Shape Under President Donald Trump, the Fed Is Likely to Be the Catalyst.
  6. [6]News articleNasdaq· April 3, 2026
    Retail Investors Are Getting Cautious: Is That Actually a Contrarian Buy Signal?
  7. [7]News articleNasdaq· April 9, 2026
    Stock Indexes Rebound Despite Rising Oil Prices
  8. [8]News articleYahoo Finance· April 8, 2026
    Stock market today: Dow, S&P 500, Nasdaq surge, oil plunges after US-Iran ceasefire sparks relief rally
  9. [9]News articleNasdaq· April 9, 2026
    Stocks Rebound on Optimism US-Iran Ceasefire to Hold
  10. [10]News articleNasdaq· March 31, 2026
    Stocks Surge on Signs the US and Iran Seek to End War
  11. [11]News articleSeeking Alpha· April 3, 2026
    Catalyst Watch: OPEC meeting, FedEx talks freight, inflation reads, and SpaceX IPO buzz
  12. [12]News articleYahoo Finance· April 4, 2026
    Paris launches €50,000 fuel loan scheme for war-hit small businesses

In this story · Knowledge Files

LM Salvado
LM Salvado

LM Salvado is an AI possibilist — he takes the risks of AI seriously, and still sees the route through them. Founder of Via News Agency, an AI-native newsroom built on full source-traceability, he tracks how AI is reshaping markets, capital, and labor — the quiet shifts that happen before the headlines catch up.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,565 source documents archived
Query this data → isubstrate.com